An annual incentive up to 20% of expenditure towards clinical trials for
bio availability and bio-equivalence subject to a maximum of INR 1.00
crore per clinical trial in Zones 1 & 2 only.
https://www.investkarnataka.co.in/wp-content/uploads/2020/11/Booklet-final-.pdf
Karnataka Industrial
Policy 2020-25 Pg.
78
Department of Commerce and Industries #49, Khanija Bhavan, South Division, Devaraj Urs Road, Bangalore-560001
No